FDA Inspection 1144428 — Matthew Milowsky, M.D.
The FDA completed an inspection of Matthew Milowsky, M.D. on June 11, 2021 in Chapel Hill, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 11, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chapel Hill, NC (United States)
Additional Details
Clinical Investigator (CI)